MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds, net issuance
costs paid of 676 and...
$20,126K
Proceeds from espp
$79K
Net cash provided by
financing activities
$20,205K
Effect of currency rate
change on cash
$6K
Net (decrease)
increase in cash, cash...
-$23,799K
Canceled cashflow
$20,211K
Inventory
-$2,369K
Stock-based compensation
$1,970K
Accounts payable
$1,533K
Depreciation and
amortization
$555K
Operating lease
liabilities and rou asset,...
$80K
Net cash used in
operating activities
-$42,318K
Canceled cashflow
$6,507K
Net cash used in
investing activities
-$1,692K
Net loss
-$40,194K
Other non-current
assets
$3,742K
Accounts receivable, net
$2,548K
Accrued expenses and
other current...
-$2,063K
Prepaid expenses and
other
$278K
Purchase of property and
equipment
$1,692K
Back
Back
Cash Flow
Tonix Pharmaceuticals Holding Corp. (TNXP)
Tonix Pharmaceuticals Holding Corp. (TNXP)
source: myfinsight.com